Back

Heart rate reduction or ventricular reverse remodeling associated with beta-blocker therapy is accompanied widespread, distinct changes in the beta1-adrenergic receptor gene signaling network

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Beta blockers Beta blockers HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Associate Professor David Peter Kao

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

4 More presentations in this session

Presentation thumbnail
Effect of beta blockers on exercise capacity in patients with heart failure undergoing cardiac rehabilitation
Presentation thumbnail
Association of beta-blocker usage with mortality following myocardial infarction in patients with COPD: a propensity score analysis from the high-risk myocardial infarction database initiative
Doctor S. Coiro (Perugia, IT)
Abstract
Presentation thumbnail
The effect of beta-blocker therapy in HF patients with high comorbidity burden: interpreting data in community setting
Doctor C. Di Nora (Udine, IT)
Presentation thumbnail
Beta blockers uptitration in patients with chronic heart failure and ICD/CRT-D: A single center study
Doctor D. Masarone (Naples, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Beta blockers

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources